# US 2026/0041636 A1 · Lipid fusion depot composition with controlled initial release, and method for preparing same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0041636 A1
- Document ID: US20260041636A1
- Status: Published application
- Kind: A1
- Application number: 18/832,671
- Filed: 2023-01-16
- Published: 2026-02-12
- Earliest claimed: 2022-01-27
- Assignees: Tionlab Therapeutics
- Applicants: Tionlab Therapeutics Co., Ltd.
- Inventors: Duck Soo Lim; Eun Joo Lee; Go Yeong Choi; Chae Lyn Kang; Su Bin Jeun
- Web page: https://patentgrep.com/patent/US20260041636A1

## CPC

- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 9/1271: Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers (liposomes as conjugates {A61K47/6911})
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/1647: {Polyesters, e.g. poly(lactide-co-glycolide)}
- A61K 38/26: Glucagons
- A61K 47/08: containing oxygen, {e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides}
- A61K 9/113: Multiple emulsions, e.g. oil-in-water-in-oil {(A61K9/0026 takes precedence)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a depot composition comprising a lipid component inside microspheres. The depot composition is capable of controlling the excessive initial burst of an active ingredient from a formulation containing a biodegradable polymer and an active ingredient and has excellent suspensibility, and thus, even when using same as an injection, a layperson can obtain the effect of the active ingredient uniformly and continuously.

## Claims

### Claim 1

A depot composition comprising microspheres comprising an oil layer (O layer) comprising a lipid component and a biodegradable polymer.

### Claim 2 (depends on 1)

The depot composition of claim 1, wherein the lipid component is glycerol dioleate (GDO) or tripalmitin, or a mixture of cholesterol and a second lipid component.

### Claim 3 (depends on 2)

The depot composition of claim 2, wherein the second lipid component is one or more selected from the group consisting of GDO, 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and tripalmitin.

### Claim 4 (depends on 1)

The depot composition of claim 1, wherein the microspheres are prepared by comprising the lipid component in an amount of 20 parts by weight or less with respect to 100 parts by weight of the biodegradable polymer.

### Claim 5 (depends on 2)

The depot composition of claim 2, wherein cholesterol is comprised in an amount of more than 0.001 moles and less than 50 moles with respect to 1 mole of the second lipid component.

### Claim 6 (depends on 1)

The depot composition of claim 1, wherein the biodegradable polymer is a polymer comprising lactide and glycolide as monomers.

### Claim 7 (depends on 1)

The depot composition of claim 1, wherein the biodegradable polymer has an inherent viscosity (25° C.) of 0.35 dL/g to 0.65 dL/g.

### Claim 8

A method for preparing a depot composition, the method comprising: preparing an oil phase (O) solution comprising a lipid component and a biodegradable polymer, or
preparing a W1/O emulsion by mixing a first water phase (W1) solution comprising a water-soluble solvent with the oil phase (O) solution; and
preparing an O/W2 emulsion or a W1/O/W2 emulsion by inputting the oil phase solution or W1/O emulsion into a second water phase 2 (W2) solution.

### Claim 9 (depends on 8)

The method of claim 8, wherein the lipid component is comprised in an amount of 20 parts by weight or less with respect to 100 parts by weight of the biodegradable polymer.

### Claim 10 (depends on 8)

The method of claim 8, wherein the first water phase and/or oil phase further comprise an active ingredient, and
the lipid component is comprised in an amount of 0.01 to 10 moles with respect to 1 mole of the active ingredient in the oil phase solution.

### Claim 11 (depends on 8)

The method of claim 8, further comprising recovering microspheres by drying and/or filtering the prepared O/W2 emulsion or W1/O/W2 emulsion and then centrifuging the emulsion.
